David A Socks
CIK 1378847 · SVP · last filed 2024-05-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.68M
Companies
2
Total Filings
36
Lifetime Open-Market Net
-$19.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Director | 1,230,846 | $11.93 | $14.68M | -$17.88M | 15 | 2024-05-24 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | SVP | 96,245 | — | — | -$1.44M | 21 | 2010-06-15 |
Recent Filings · Page 3 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-03-09 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −10,000 | -$93.0K | EDGAR |
| 2010-02-09 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −12,500 | -$128.2K | EDGAR |
| 2010-01-12 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −12,500 | -$125.8K | EDGAR |
| 2010-01-04 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Exer (M) | +25,000 | $10.0K | EDGAR |
| 2009-12-18 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −2,500 | -$25.0K | EDGAR |
| 2009-12-16 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −10,000 | -$93.4K | EDGAR |
| 2009-11-10 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −12,500 | -$125.1K | EDGAR |
| 2009-10-13 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −12,500 | -$145.0K | EDGAR |
| 2009-09-15 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Sell (S) | −12,500 | -$133.6K | EDGAR |
| 2009-09-02 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.